Systematic evaluation of therapeutic effectiveness of Azvudine in treating COVID-19 hospitalized patients: a retrospective cohort study
Our study demonstrates that Azvudine has a significant positive impact on the clinical recovery of hospitalized patients with COVID-19. These findings provide important support for the use of Azvudine as a therapeutic option for COVID-19, given the current divergent views on its therapeutic efficacy and its importance in public health and medical care.
Authors
- Zihan Yuan
- Wanbing Liu
- Li Wang (ORCID: https://orcid.org/0009-0009-6933-1354)
- Lei Liu (ORCID: https://orcid.org/0000-0001-6764-3260)
- Ying-Kai Xu (ORCID: https://orcid.org/0000-0003-2945-2724)
- Yuan Huang
Institutions
- Central Hospital of Wuhan (CN)
- Wuhan General Hospital of Guangzhou (CN)
- First Affiliated Hospital of Henan University (CN)
- Wuhan University of Science and Technology (CN)
- General Hospital of Central Theater Command
Publication Details
- Journal
- Frontiers in Cellular and Infection Microbiology
- Published
- 2024-11-07
- DOI
- https://doi.org/10.3389/fcimb.2024.1453234
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00